ANTOINETTE M DEINGENIIS-DEPASQUALE

Allopathic & Osteopathic Physicians|Family Medicine KINNELON, NJ NPI 1922192517

General Payments — all program years on this page

$5,702.79

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 448
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $274.25 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $274.2517

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $107.287
PFIZER INC. $52.313
ABBVIE INC. $33.062
Novo Nordisk AS $29.972
Exact Sciences Corporation $21.521
Lilly USA, LLC $16.951
GlaxoSmithKline, LLC. $13.161

By program year

Program yearAmountRecords
2018 $1,341.80107
2019 $1,373.12108
2020 $447.0934
2021 $627.0650
2022 $811.3372
2023 $828.1460
2024 $274.2517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096933673 Novo Nordisk Inc $14.44 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097100740 Novo Nordisk Inc $15.53 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103619240 ABBVIE INC. $17.26 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103619242 ABBVIE INC. $15.80 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104422583 AstraZeneca Pharmaceuticals LP $16.38 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104607174 AstraZeneca Pharmaceuticals LP $13.38 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104735183 AstraZeneca Pharmaceuticals LP $14.86 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105394895 AstraZeneca Pharmaceuticals LP $17.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105471053 AstraZeneca Pharmaceuticals LP $14.16 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105643970 AstraZeneca Pharmaceuticals LP $17.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105886733 AstraZeneca Pharmaceuticals LP $14.50 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114631602 Exact Sciences Corporation $21.52 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116577614 GlaxoSmithKline, LLC. $13.16 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131612218 PFIZER INC. $20.45 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131613059 PFIZER INC. $14.90 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131613063 PFIZER INC. $16.96 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136048023 Lilly USA, LLC $16.95 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.